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The complete amino acid sequence of human retinal S-antigen (48 kDa protein), a retinal protein involved in the visual 
process has been determined by cDNA sequencing. The largest cDNA was 1590 base pairs (bp) and it contained an entire 
coding sequence. The similarity of nucleotide sequence between the human and bovine is approximately 80%. The pre- 
dicted amino acid sequence indicates that human S-antigen has 405 residues and its molecular mass is 45050 Da. The 
amino acid sequence homology between human and bovine is 81%. There is no overall sequence similarity between 
S-antigen and other proteins listed in the National Biomedical Research Foundation (NBRF) protein data base. How- 
ever, local regions of sequence homology with a-transducin (Ta) are apparent including the putative rhodopsin binding 
and phosphoryl binding sites. In addition, human S-antigen has sequences identical to bovine uveitopathogenic sites, 
indicating that some types of human uveitis may in part be related to the animal model of experimental autoimmune 
uveitis (EAU). 
S-antigen; 4%kDa protein; Human cDNA; Amino acid sequence; Uveitis; Visual process 
1. INTRODUCTION 
Vision begins with the conversion of light energy 
into an electrical impulse (phototransduction) 
[ 1,2]. This is accomplished by the outer segments 
of the photoreceptor cells of the retina. Initial ab- 
sorption of light converts rhodopsin into an active 
form (R*) which interacts with and activates hun- 
dreds of transducin (Td) molecules [3-51. The ac- 
tivated Td interacts with phosphodiesterase 
(PDE), each molecule of which hydrolyzes 
thousands of molecules of cyclic guanosine 
monophosphate (cGMP) [5-71. The decrease of 
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cGMP concentration blocks the entry of sodium 
ions by closing Na+ channels [&lo]. Thus, light 
energy is amplified to generate a membrane poten- 
tial. This electrical signal is processed into a 
neuronal signal by other retinal cells. The rhodop- 
sin bleached by light is then phosphorylated by 
rhodopsin kinase at multiple serines and 
threonines near the carboxyl terminus [l I]. S- 
antigen binds to the R* and R*P to play a negative 
regulatory role in the visual process [12-141. As a 
contrasting hypothesis, S-antigen does not bind to 
R*P but directly inactivates PDE [15,16]. Many 
similar proteins have been shown to be involved in 
the visual system, the adenyl cyclase system and 
hormone receptor signal transduction [171. 
Therefore, it is possible that the adenyl cyclase 
system has a protein similar to S-antigen which 
plays a role in negative regulation. However, only 
in the photoreceptor cells in retina and 
pinealocytes in piileal gland, has S-antigen been 
detected by immunocytochemistry [ 181. 
S-antigen is also a highly antigenic protein 
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responsible for the induction of experimental 
autoimmune uveitis (EAU) [19,20]. Recently the 
structure of bovine S-antigen [21-231 and sites 
responsible for EAU have been characterized [24]. 
In order to understand the functional role of S- 
antigen in phototransduction and in the induction 
of human uveitis, it is important to determine the 
structure of human S-antigen. Here, we report the 
amino acid sequence of human S-antigen and 
discuss its role in the visual process and in human 
disease. 
2. MATERIALS AND METHODS 
Human retinal library (generous gift from Dr .I. Nathans, 
Genentech) was screened with ‘*P-labelled 5’ noncoding se- 
quence of a bovine S-antigen cDNA probe (331 bp long) as 
described [22,23]. Initially, 1 x 10’ plaques were screened giving 
1 x 10’ positive plaques. Most of the clones seem to have nearly 
full-size cDNA insert. Nine cDNA inserts were subcloned into 
bluescribe plasmid (Stratagene, San Diego, CA) and amplified. 
Restriction enzyme analysis was performed with EcoRI, 
BarnHI, HuelII, BgfiI, KpnI, SacI, XhoI and PslI enzymes (In- 
ternational Biotechnologies Inc., New Haven, CT). DNA se- 
quences were obtained by the dideoxy chain termination 
method [25] modified for [?%]ATP (Amersham Inc., Arlington 
Heights, IL) [21]. Specific oligonucleotide primer probes (15 or 
20 mer) were made on an automated DNA synthesizer (Model 
380B, Applied Biosystem, Inc., Foster City, CA). 
3. RESULTS AND DISCUSSION 
Several positive plaques for human S-antigen 
cDNAs were obtained from a human retina cDNA 
library by hybridization with bovine S-antigen 
cDNA probes [21-231. Nine of them contained the 
full coding sequence of S-antigen and had the same 
restriction sites for Bgfll, EcoRl, Kpnl, Sac1 and 
Xhol (not shown). Three cDNAs out of nine 
clones had different Haelll sites in the coding se- 
quence indicating that S-antigen may be polymor- 
phic, since the cDNA library was constructed from 
multiple retinas [26]. The largest cDNA insert, 
1590 bp was sequenced (fig.1). This cDNA insert 
has a poly-A tail at the 3’ end but lacks 
loo-150 bp at the 5’ end. The bovine and mouse 
mRNA size is approximately 1600-1700 
nucleotides (nt). The sequence similarity between 
human and bovine DNA is approximately 80% 
(fig.2). However, similarity in the non-coding se- 
quence is less than 30%, while in the coding se- 
quence it is 86%. Both human and bovine cDNAs 
have a long 5’ noncoding sequence (300-400 nt) 
40 
TGCAAGAGAGCCTGCTTAAAAAGCTCGGGAGCAACACGTACCCCTTTCTCCTGACGTTTC 
550 560 570 580 590 600 
oVLPCs”MLQPAPQDsGKsCl47 
CTGACTACTTGCCCTGTTCACTGTTGCAGCCAGCTCCGTCC~ 
610 620 630 640 650 660 
G"DFE"KAFATDSTDAEEDKl67 
GTGGGGTTGACTTTGAGGTCAAAGCATTCGCCACAGACAG~*GG*C* 
670 680 690 700 710 720 
IPKKSSVRYLIRS"OHAPLEl87 
AAATCCCCAAGAAGAGCTCCGTGCGATATCTGATCCGTAGTGTAC~GCATGCCCCACTTG 
730 740 750 760 770 780 
MGPQPRAEAT”QFFMSDKPL207 
AGATGGGTCCCCAGCCCCGACTGACGCCACCTGGCAGTTGCCC~ 
790 800 810 820 830 840 
HLA”SLNREIYFHGEPIPVT227 
TGCACCTTGCGGTCTCTCTCAACAGAGAGATCTATTTCCATGGGG~GCCC~TCCCTGTG~ 
850 860 870 880 890 900 
"T"TNNTEKT"KKIKAC"EQ247 
CCGTGACTGTCACCAATAACACAGAGAAGACCGTGAAGAAC 
910 920 930 940 950 960 
“AN”VLYSSDYY”KP”A”EE267 
AGGTGGCCAATGTGGTTCTCTACTCGAGTGATTATTACGTG 
970 980 990 1000 1010 1020 
AQEK"PPNSTLTKTLTLLPL287 
AAGCGCAAGAAAAAGTGCCACCAAACAGCACTTTGACCAAG~CGTTG~CGCTGCTGCCCT 
1030 1040 1050 1060 1070 1080 
LANNRERRGIALDGKIKHED307 
TGCTGGCTAACAATCGAGAGG*G~GGCATTGCCCTGGAGCACGAGG 
1090 1100 1110 1120 1130 1140 
TNLASSTIIKEGIDRT"LGI327 
ACACAAACCTTGCCTCCAGCACCATCATTAAGGAGGGCAT 
1150 1160 1170 1180 1190 1200 
L”SYQIK”KLT”SGFLGELT347 
TCCTGGTGTCTTACCAGATCAAGGTGAAGCTCACAGTGTGTC*GGCTTTCTGGG*G*GCTC* 
1210 1220 1230 1240 1250 1260 
SSE"ATE"PFRLnHPQPEDP367 
CCTCCAGTGAAGTCGCCACTGAGGTCCCATTCCGCCTCATCCTG~GG*CC 
1270 1280 1290 1300 1310 1320 
AK E S IQDANL"FEEFARHNL387 
CAGCTAAGGAAAGTATTCAGGATGCAAATTTAGTTTTTGATC 
1330 1340 1350 1360 1370 1380 
KDAGEAEEGKRDKNDADE 405 
TGAAAGATGCAGGAGAAGCTGAGGAGGGGAAGAGAGACAA 
1390 1400 1410 1420 1430 1440 
1450 1460 1470 1480 1490 1500 
ACAGTTTAGTCCTTTGGAGTTATGCTGCTGCGATT* 
1510 1520 1530 1540 1550 1560 
AAGCTTGTTTGTTCTCCCCTGGAAAAAAAA 
1570 1580 1590 
Fig. 1. The sequence of cDNA clone for human S-antigen. The 
upper line shows predicted amino acid sequence and lower line 
shows nucleotide sequence. Numbers on the right indicate 
amino acid residues and subscripts of nucleotides indicate 
nucleotide residues from 5’ end. The underlined nucleotides 
preceding the S-antigen sequences denote the first methionine 
codon and in frame termination codon. 
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Fig.2. Homologies of human and bovine S-antigen to the consensus sequence of GTP/GDP binding sites. The numbers in parentheses 
represent the amino acid residues. Consensus spacing of consensus sequences are either 40-80 or 130-170 amino acid residues between 
the first and second elements and 40-80 amino acid residues between the second and third sequence elements. X indicates any amino 
acid residues. 
and a relatively short 3’ noncoding sequence 
(-150 nt). 
The initiation codon at base 222 is in a sequence 
which conforms well to the Kozak consensus se- 
quence (TAACATG compared with CANCATG) 
[27]. The open reading frame between 222 and 
1436 appears to contain the entire coding sequence 
for S-antigen, a protein consisting of 405 amino 
acids with a calculated molecular mass of 45050 
Da. The sequence identity at the protein level be- 
tween human and bovine is 81%. 
Another small open reading frame between 15 
and 200 which could encode 60 amino acid residues 
is observed and it has no similarity with any se- 
quence in the NBRF database. Bovine S-antigen 
cDNA has a similar open reading frame in the 5’ 
noncoding sequence. There is also no significant 
nucleotide or amino acid sequence similarity be- 
tween the small open reading frames in human and 
bovine 5 ’ noncoding sequences. Such short open 
reading frames in the 5’ noncoding region have 
been reported in other cDNAs [28,29] and they ap- 
pear to have influence on their translation [30]. 
Although the function of S-antigen in the 
phototransduction process is not well understood, 
a possible relationship with GTP binding proteins 
exists. S-antigen and GTP-binding proteins have 
some interesting local sequence similarities. GTP 
binding proteins including proto-oncogenes refer- 
red to as ras proteins, bacterial elongation factors 
(EF-Tu and EF-G), a-tubulin, adenylate kinase, 
signal-transducing G-proteins and TLY contain 
highly conserved functional sequences [3 11. The 
striking feature is at the GTP binding site, in- 
cluding a consensus sequence composed of three 
elements, Gly/Ala-X-X-X-X-Gly-Lys, Asp-X-X- 
Gly and Asn-Lys-X-Asp with conserved spacing. 
Human and bovine S-antigens have four such se- 
quences as shown in fig.2, but in the reverse orien- 
tation. They have phosphoryl binding consensus 
sites Ala-X-X-X-X-Gly-Lys and Asp-X-X-Gly 
with the right consensus spacing. In addition, both 
S-antigens have Gly-X-X-X-X-Gly-Lys elements at 
295-301 (human) and 292-298 (bovine) without 
consensus spacing. These three sites may form 
binding pockets for phosphates [32]. 
In contrast to the phosphoryl binding sites, there 
is no obvious candidate for guanine binding sites in 
the S-antigen sequence [31]. The closest homology 
in bovine is An-Lys-Pro-Ala with the right spac- 
ing. Thus, S-antigen may not bind to GTP. When 
Asp of Asn-Lys-X-Asp is replaced by Asn as Asn- 
Lys-X-Asn in the ras mutant protein, the affinity 
for GTP is lowered by a factor of 100 [33]. Addi- 
1 
EA (373-393) Human 
A EY (372-392) Bovine I 
S-Ag 
C LF (326-3501 T,, -Transducin 
t 
ADP-Ribosylation Site 
Fig.3. Homologies of human, mouse and bovine S-antigen 
sequences to Tcu sequence. Dark boxes indicate the identical 
amino acid residues and half shade boxes indicate conserved 
amino acid residues. Bovine sequence was published [21-231. S- 
antigen was not ADP-ribosylated by pertussis toxin [23]. The 
numbers in parentheses represent the amino acid residues. 
41 
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Fig.4. Sequence similarity of human S-antigen peptides M and N to k and 3. Peptides M, N, K and 3 of bovine S-antigen are uteitogenic 
sites for experimental animals [24,44]. Solid lines between sequences indicate the identical amino acid residues and dotted lines indicate 
conserved amino acid residues. (I = V = L, K = R). 
tionally, in the same protein, a Lys or Tyr replace- 
ment of the Asp in Asn-Lys-X-Asp abolishes 
GTP-binding activity [34]. We did not observe 
binding of the ATP to S-antigen (not shown), 
which is consistent with other results [12-141. 
Thus, it is reasonable to speculate that R*P binds 
to putative phosphoryl pocket of S-antigen. 
The second interesting regional similarity of S- 
antigen is with a site near the carboxyl terminus of 
TLY where pertussis toxin catalyzes ADP- 
ribosylation [35] as shown in fig.3. Modification 
of a-transducin by pertussis toxin results in mark- 
ed reduction of the light dependent GTPase activi- 
ty as well as the light stimulation of PDE [36]. This 
suggests that the carboxyl terminus of Tcu plays a 
critical role in the interaction with R*. We 
speculate that S-antigen and Ta bind to R* at the 
same site. 
Thus, the structure of S-antigen is consistent 
with the observation of Kuhn et al. [12-141 that it 
interacts with R* at the same site as Tcu in a com- 
petitive manner [12]. Initial S-antigen and R* bin- 
ding may be very weak, as reported previously 
[12-141. However, when rhodopsin is phos- 
phorylated with rhodopsin kinase, secondary 
binding may take place: S-antigen phosphoryl 
pockets may bind to the phosphate groups of R*P 
leading to tighter binding than R*/Ta thereby 
quenching the capacity of TLY to activate PDE. The 
Ta binding site on rhodopsin is estimated to be at 
the carboxyl terminus, residues 317-33937 or loop 
V38, which is close to the multiple phosphorylation 
sites [ 111. Furthermore, carboxyl terminus amino 
acid residues (approximately 10) were cleaved from 
the phosphorylated rhodopsin by proteinase. This 
rhodopsin increases PDE activity higher than the 
original level [39]. This result suggests that the car- 
boxy1 terminus does not interact with TLY. The 
phosphorylation of rhodopsin is an important pro- 
42 
cess for inactivation of the phototransduction 
cascade. 
S-antigen is also present in the pineal gland 
where there is no detectable rhodopsin [40]. We 
speculate that S-antigen binds to phosphorylated 
/3-adrenergic receptors since the &adrenergic 
receptor has some sequence similarity to rhodopsin 
and is also known to be inactivated by 
phosphorylation [41]. A recent report indicates 
that S-antigen indeed inhibits the /3-adrenergic 
signal transduction cascade [42]. 
Recently, the immunopathogenic sites of bovine 
S-antigen, peptides M, N, K and 3 for the induc- 
tion of EAU in the Lewis rat have been character- 
ized [24]. Human S-antigen is also capable of 
inducing EAU in experimental animals including 
Lewis rats, guinea pigs and monkeys (in prepara- 
tion) with similar pathology [43]. Interestingly, 
human S-antigen has an identical sequence to 
bovine S-antigen M and N peptides (306-317), fur- 
thermore it has sequence similarity between pep- 
tides M and N and peptides K and 3 (fig.4). The 
multiple repeated structures may play an impor- 
tant role in the induction of EAU. These findings 
would indicate that EAU induced by peptides M 
and N could have clinical relevance to some types 
of human uveitis. As mentioned previously, 
however, human S-antigen seems to be polymor- 
phic, perhaps indicating that the susceptibility to 
disease is in part due to the heterogeneity of the S- 
antigen structure in each individual. 
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